MedStar Washington Hospital Center
MedStar Washington Hospital Center
110 Irving St. NW C2149
Washington, DC
The Washington Cancer Institute at the MedStar Washington Hospital Center is a comprehensive cancer center home to a number of surgical oncology specialists and offering the latest procedures for treating peritoneal mesothelioma.
Why MedStar Washington?
MedStar Washington Hospital Center employs top doctors in their field and participates in cutting-edge clinical trials that help develop new methods of treating peritoneal mesothelioma. The hospital also includes some of the key features required for the highest quality of treatment and care, including:
Personalized Treatment
At the Washington Cancer Institute doctors use multimodal treatment methods combining surgery, chemotherapy, and the HIPEC procedure to craft a unique regimen for their patients to promote the most optimistic prognosis.
A Healing Environment
The facility at MedStar Washington Hospital Center is designed to include some of the country’s most knowledgeable cancer specialists. The hospital has grown significantly over the years and is driven by a culture of innovation and a commitment to quality.
Latest Technology
The Washington Cancer Institute prides itself on giving patients access to the most up to date and advanced technology for treating their cancer. It is a national model for cancer treatment and a leader in the region. The facility boasts an extensive array of imaging technologies essential for treating mesothelioma.
MedStar Washington Hospital Center
Why Choose the MedStar Washington Hospital Center?
- The high volume of their facility
- Access to the most advanced technology
- Doctors who care about the patients they treat
Free Mesothelioma Guide
Get the complete guide to fight mesothelioma.
In our free guide, you'll learn about:
- Top treatment for your diagnosis
- How you can live longer
- Ways survivors beat the odds
*Absolutely Free. No Credit Card Required. Free Shipping. Sent Overnight
MedStar Washington Hospital Center
110 Irving St. NW C2149 Washington, D.C.
Doctors: Dr. Paul Sugarbaker
Focus: Peritoneal mesothelioma
MedStar Washington Hospital Center is the home of the Washington Cancer Institute, a leader in the research and development of new methods for treating peritoneal mesothelioma. The well-respected Dr. Paul Sugarbaker works at the institute, and there are other benefits to receiving treatment here:
- Dr. Paul Sugarbaker developed the cytoreduction with heated intraperitoneal chemotherapy procedure, which has revolutionized mesothelioma treatment and is a staple of peritoneal mesothelioma treatment approach at the center.
- Personalized treatment helps patients receive the best care for their unique diagnosis.
Innovation in Mesothelioma Treatment: Cytoreduction and HIPEC
One of the most significant advantages of the MedStar Washington Hospital Center is that they are one of the few hospitals to offer cytoreductive surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for treating peritoneal mesothelioma.
The process begins with the complex cytoreductive surgery, which involves the removal of the abdominal lining and the meticulous resection of all cancerous tissue. Then, the HIPEC procedure is used to administer chemotherapy directly to the abdomen. This process reduces the toxicity in the patient’s body due to chemotherapy treatment while giving doctors the ability to use stronger doses.
Dr. Paul Sugarbaker
The pioneer of cytoreduction and HIPEC procedure, Dr. Paul Sugarbaker, serves as the Director of Surgical Oncology at the Washington Cancer Institute at MedStar Washington.
Until the development of the HIPEC procedure by Dr. Paul Sugarbaker in the 1980s, chemotherapy could only be administered up to a certain dosage before becoming toxic. Since most chemotherapy drugs are delivered through an IV, they circulate throughout the patient’s entire body. The HIPEC procedure allows surgeons to introduce chemotherapy directly into the abdomen targeting peritoneal tissue at higher doses, which makes it more effective while being less toxic to the patient.
With this procedure, patients have extended their life expectancy an average of 3 years longer than their pre-operation prognosis estimated. Patients who are diagnosed with peritoneal mesothelioma and do not undergo surgery of any kind have an average life expectancy of 11 months. There have even been quite a few instances where patients live for more than five years after their recovery from the cytoreduction with HIPEC treatment. According to the National Cancer Institute, the median survival for a patient who has undergone the cytoreduction with HIPEC procedure is 7 years, with some patients in rare cases living up to fifteen years.
Read About Mesothelioma Survivors
Get our free survivors guide with inspiring stories of overcoming mesothelioma.
Learn More
Read Survivor Stories
Get our free survivors guide with inspiring stories of overcoming mesothelioma.
In our free survivors guide, you'll learn:
- How survivors of 10+ years outlived their prognosis
- Top treatments that survivors swear by
- Ways to improve your prognosis and quality of life
Jodi Page is a survivor of stage 2 epithelioid mesothelioma for over 17 years.
*Absolutely Free. No Credit Card Required. Free Shipping. Sent Overnight
Is MedStar Washington Hospital Center Right for You?
The Washington Cancer Institute at The MedStar Hospital Center is one of the top peritoneal mesothelioma treatment centers in the country. The experience and expertise offered by MedStar staff give patients the most comprehensive treatment plans available, including:
- Specialized treatment procedures
- Decades of research and experience treating mesothelioma
- Access to top surgeons in the field
If this cancer center sounds like the right fit for your treatment needs, we can help get you connected. Contact one of our patient advocates at 1-888-385-2024 to get in touch with the Washington Cancer Institute or get answers to your questions through our Doctor Match Program.
